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OBJECTIVE—Long-standing type 1 diabetes is associated with
deﬁcits on neurocognitive testing that suggest central white
matter dysfunction. This study investigated whether diffusion
tensor imaging (DTI), a type of magnetic resonance imaging that
measures white matter integrity quantitatively, could identify
white matter microstructural deﬁcits in patients with long-
standing type 1 diabetes and whether these differences would be
associated with deﬁcits found by neurocognitive tests.
RESEARCH DESIGN AND METHODS—Twenty-ﬁve subjects
with type 1 diabetes for at least 15 years and 25 age- and
sex-matched control subjects completed DTI on a 3.0 Tesla
scanner and a battery of neurocognitive tests. Fractional anisot-
ropy was calculated for the major white matter tracts of the
brain.
RESULTS—Diabetic subjects had signiﬁcantly lower mean frac-
tional anisotropy than control subjects in the posterior corona
radiata and the optic radiation (P  0.002). In type 1 diabetic
subjects, reduced fractional anisotropy correlated with poorer
performance on the copy portion of the Rey-Osterreith Complex
Figure Drawing Test and the Grooved Peg Board Test, both of
which are believed to assess white matter function. Reduced
fractional anisotropy also correlated with duration of diabetes
and increased A1C. A history of severe hypoglycemia did not
correlate with fractional anisotropy.
CONCLUSIONS—DTI can detect white matter microstructural
deﬁcits in subjects with long-standing type 1 diabetes. These
deﬁcits correlate with poorer performance on selected neurocog-
nitive tests of white matter function. Diabetes 57:3083–3089,
2008
T
ype 1 diabetes is a complex metabolic disease
that can have devastating effects on multiple
organ systems. Although complications involv-
ing the kidneys, nerves, and eyes have long been
recognized, the effect of diabetes on cognition has not
been as clearly understood. Patients with type 1 diabetes
have been found to have deﬁcits on standard neurocogni-
tive tests of information processing (1–4), psychomotor
efﬁciency (1,2), motor speed (3,5–7), visuoconstruction
(4,8), attention (4), somatosensory examination, motor
strength (7), and executive function (9). Based on the type
of cognitive deﬁcits observed in patients with diabetes,
there has been speculation that abnormalities in white
matter may be at least partly responsible for cognitive
dysfunction, particularly in patients with type 1 diabetes
(2). Supporting this hypothesis, several studies have found
gross morphological changes (10) and reduced white
matter volume as measured by voxel-based morphometry
(4) in patients with type 1 diabetes. However, prior studies
have not looked speciﬁcally at the microstructural aspects
of white matter integrity.
Over the last decade, a new type of magnetic resonance
imaging (MRI) called diffusion tensor imaging (DTI) has
been developed that is uniquely suited to assess white
matter microstructure. DTI measures the magnitude and
directionality of water diffusion in tissues, which may
permit identiﬁcation of tissue injury before it has pro-
gressed to the point of detection by more conventional
imaging techniques. Without barriers, water molecules
move uniformly in all directions, a phenomenon referred
to as isotropic diffusion. In the presence of barriers, such
as cell membranes, ﬁbers, and myelin, the diffusion rate is
greater in one direction, which is termed anisotropic
diffusion. Fractional anisotropy provides a quantitative
measure of the degree of diffusion anisotropy. Fractional
anisotropy is high in regularly organized and structured
white matter, such as the corpus callosum, and is lower in
less organized tissues, such as gray matter (11,12). Previ-
ous DTI studies have shown that reduced fractional an-
isotropy correlates to cognitive dysfunction in a variety of
conditions, including schizophrenia (13,14), depression
(15), chronic alcohol use (16), Alzheimer’s disease (17,18),
and chronic cocaine use (19). In addition, a decrease in
brain fractional anisotropy correlated negatively with viral
load in patients with known HIV infection (20). This is of
particular interest because patients living with HIV have
many of the cognitive impairments that patients with type
1 diabetes exhibit, including decreased attention and
speed of information processing (11).
To determine whether abnormalities in white matter
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identiﬁed in patients with longstanding type 1 diabetes, we
used DTI to obtain quantitative data about white matter
structural integrity in this population. We hypothesized
that patients with long-standing type 1 diabetes will have
decreased fractional anisotropy when compared with
matched controls. To determine whether any identiﬁed
reductions in fractional anisotropy correlated with abnor-
malities in neurocognitive function, subjects also com-
pleted a battery of standardized neurocognitive tests to
assess performance on tasks believed to be supported by
white matter regions. This analysis was done to test the
hypothesis that fractional anisotropy will correlate with
neurocognitive test performance in patients with type 1
diabetes, speciﬁcally with tests that depend on white
matter integrity.
RESEARCH DESIGN AND METHODS
Twenty-ﬁve type 1 diabetic subjects were recruited from the Endocrine
Clinics at the University of Minnesota Medical Center–Fairview and through
institutional review board–approved ﬂiers distributed around the University of
Minnesota campus. To ensure that the subjects resembled those included in
previous studies assessing cognitive function in diabetes (3,21), only subjects
with a diabetes duration of 15 years or more were eligible for participation.
Exclusion criteria included a history of or current evidence of any substance
abuse disorder other than tobacco or caffeine dependence; severe psychiatric
disorder, including major depressive disorder; seizure disorder (not related to
hypoglycemia); transient ischemic attack; stroke; head injury; other diseases
of the central nervous system; chemotherapy; and any condition that pre-
cluded the performance of MRI (weight 300 lbs [subjects of this size cannot
ﬁt into the magnetic resonance instrument], presence of metal implants or
shrapnel, claustrophobia, etc.). Education history was also assessed. Twenty-
ﬁve healthy volunteers without diabetes and free of the exclusion criteria
were recruited from the University of Minnesota community to match the
subjects with respect to age and sex (Table 1).
All subjects reported to the General Clinical Research Center at the
University of Minnesota for neurocognitive testing after breakfast or lunch. On
a separate day but within 2 weeks of the neurocognitive testing, subjects
reported to the Center for Magnetic Resonance Research at the University of
Minnesota for DTI, again after either breakfast or lunch. Diabetic subjects
were instructed to manage their condition in their usual manner. Upon arrival,
diabetic subjects performed ﬁngerstick blood glucose testing to ensure that
blood glucose was between 5.5–13.9 mmol/l (100–250 mg/dl). If blood glucose
was outside of this glycemic range, appropriate therapy was administered by
the investigator to bring them into target within1ho rt h estudy was
rescheduled. A1C was also measured in diabetic subjects using a blood sample
obtained on the day of neurocognitive testing.
Neurocognitive testing. The neurocognitive testing battery included the
Wechsler Abbreviated Scale of Intelligence (WASI) and tests of psychomotor
speed and executive function that have been found to be impaired in subjects
with white matter disease (22,23). These tests included the Paced Auditory
Serial Addition Test (PASAT), the Digit Vigilance Test (DVT), Trails A and B,
the Benton Judgment of Line Orientation Test (JLO), the Rey-Osterreith
Complex Figure Drawing Test (Rey-O), the Grooved Pegboard Test, and the
Conners’ Continuous Performance Test–Second Edition (CPT-II). Each test-
ing session lasted 2–3 h. All tests were administered and scored by trained
personal and interpreted by one of the authors (F.S.A.). Comparison of
diabetic subjects and control subjects was based on the Rey-O (copy and
delayed recall), the JLO, the Grooved Pegboard Test (dominant and nondomi-
nant hands), the DVT (total time needed to complete), the WASI (full-scale IQ
score), and the PASAT (with numbers being separated by 2.4, 2.0, 1.6, and
1.2 s). The System Checklist-90-R was also given as a psychological screen.
MRI collection. DTI was performed by positioning the ﬁeld of view to cover
the entire cerebrum. Acquisition parameters for the axially acquired, dual spin
echo, single shot, echo planar, diffusion-weighted sequence were repetition
time 10,500 ms, echo time 98 ms, matrix 128  128, ﬁeld of view 256 mm, slice
thickness 2 mm, 64 contiguous slices, 2 averages, and a b value 1,000. A
volume without diffusion weighting and 12 volumes with noncollinear diffu-
sion directions were acquired. A B0 ﬁeldmap sequence with identical voxel
parameters to the DTI scan was acquired after the DTI sequence. A three-
dimensional T1 Magnetization Prepared Rapid Gradient Echo sequence with
repetition time 2,530 ms, echo time 3.63 ms, inversion time 1,100 ms, isotropic
voxel 1 mm, ﬁeld of view 256 mm, and matrix 256  256 was also acquired to
provide anatomical information.
DTI data processing. Diffusion-weighted images were processed using tools
from the FMRIB Software Library (FSL) (24). Eddy current-correction of the
individual diffusion-weighted echo-planar images was performed using an
afﬁne transformation (25), and magnetic ﬁeld susceptibility effects were
corrected using the B0 ﬁeldmap image. The diffusion tensor was calculated
using the nondiffusion and 12 diffusion images, and fractional anisotropy maps
were created using eq. 1 below, where FA is fractional anisotrophy and 1, 2,
and 3 represent values along the three major axes of diffusion (26).
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The mean fractional anisotropy was computed for the white matter of four
brain regions deﬁned by anatomical landmarks that include the genu and
splenium of the corpus callosum and the anterior and posterior commisures
(Fig. 1A). The Tract-Based Spatial Statistics (TBSS) analysis program bundled
with FSL (27) was used to determine average fractional anisotropy values at
the center of several tracts of interest. TBSS generated a fractional anisotropy
skeleton of the major white matter tracts of the brain for each subject. The
fractional anisotropy map from the control subject with a brain size at the
median for the controls was used to align the fractional anisotropy maps from
the other control subjects and diabetic subjects. Once the fractional anisot-
ropy maps were aligned, a common white matter skeleton was generated and
then further segmented into anatomically deﬁned tracts using the primary
eigenvector information for the target subject’s DTI data based on atlas
information from Mori et al. (28). These tracts were selected on the basis of
relative size and ease of differentiation from surrounding tracts. The resulting
tracts from this procedure included bilateral forceps minor, cingulum bundle,
medial corona radiata, superior longitudinal fasciculus, and optic radiation
(Fig. 2A). Additionally, six regions of interest (genu, rostral body, anterior
midbody, posterior midbody, isthmus, and splenium; Fig. 2A) in the corpus
callosum were generated using standardized subdivisions (29).
Comparison of diabetic subjects and control subjects was done with three
separate groups of neural regions: 1) superior frontal region, inferior frontal
region, occipital region, and region superior to corpus callosum (Fig. 1A); 2)
optic radiation, splenium of the corpus callosum, and posterior corona radiata
(Fig. 2A); and 3) forceps minor, nonsplenium subdivisions of the corpus
callosum (genu, rostral body, anterior midbody, posterior midbody, and
isthmus), right cingulum, left cingulum, right superior longitudinal fasciculus,
left superior longitudinal fasciculus, and medial corona radiata (Fig. 2A).
Statistics. Neurocognitive test scores were compared between diabetic
subjects and control subjects using t tests as an initial screening. Tests
thought to be associated with white matter function were compared simulta-
neously in a general linear mixed model (SAS Proc Mixed) with a random
intercept for each subject-pair and an unstructured covariance matrix for the
repeated test scores within subjects. The same model was used with the three
groups of brain regions to compare fractional anisotropy measurements
between diabetic subjects and control subjects. Results are reported as
mean  SE. Spearman correlation is reported as a measure of association. All
computations were performed in SAS version 9.1.3 (SAS Institute, Cary, NC).
Throughout this statistical analysis, all results were corrected for multiple
comparisons.
TABLE 1
Characteristics of subjects
Subjects with type
1 diabetes
Control
subjects
n 25 25
Age 45.1  10.5 45.6  10.8
Sex (F/M) 17/8 17/8
Education (years) 16.7  1.9 16.1  2.3
Duration of diabetes (years) 30.3  10.8 NA
A1C (%) 7.4  1.0 NA
Blood glucose before MRI
(mmol/l mg/dl	) 9.3  3.6 (168  64) NA
Blood glucose before
neurocognitive testing
(mmol/l mg/dl	) 8.4  2.7 (152  49) NA
Data are means  SD. NA, not applicable.
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Demographic data. Clinical and demographic character-
istics of the 25 type 1 diabetic subjects and the 25 age- and
sex-matched healthy controls are summarized in Table 1.
The diabetic subjects and controls were similar in all of
the demographic measures collected. Three diabetic sub-
jects reported a history of retinopathy, two reported a
history of gastroparesis, and three reported histories of
both retinopathy and neuropathy. All but one subject who
reported retinopathy had intervention (laser therapy or
vitrectomy). No diabetic subjects reported a history of
nephropathy. Fifteen of the 25 diabetic subjects reported a
history of severe hypoglycemia, deﬁned as having seizures,
loss of consciousness, or needing another person’s help to
treat the symptoms of low blood glucose.
Neurocognitive testing data. No tests included in our
battery distinguished type 1 diabetic subjects from control
subjects. However, diabetic subjects appeared to have a
tendency to perform more poorly on the Rey-O, a test
believed to be a measure of white matter function that
requires a high degree of visuospatial orientation and
planning. This test is scored based on the number of
correctly copied elements, and the diabetic subjects had a
mean score of 31  0.6, and the controls scored 33  0.6
(P 
 0.063).
DTI data. In the four large regions of analysis (inferior
frontal, superior frontal, superior to the corpus callosum,
and occipital regions with 15% overlap between the
frontal regions and the region superior to the corpus
callosum), fractional anisotropy was lower but not signif-
icantly in type 1 diabetic subjects (Fig. 1). In more speciﬁc
major white matter tracts, diabetic subjects had signiﬁ-
cantly lower fractional anisotropy than control subjects in
both the posterior corona radiata (0.443  0.004 vs.
0.471  0.004, P  0.0001) and the optic radiation (0.361 
0.004 vs. 0.380  0.004, P 
 0.0017) (Fig. 2). Type 1
diabetic subjects also tended to have lower fractional
anisotropy than control subjects in the splenium (0.806 
0.006 vs. 0.820  0.006, P 
 0.0947) and the posterior body
of the corpus callosum (0.805  0.007 vs. 0.821  0.007,
P 
 0.1397).
Correlation of DTI and neurocognitive testing data.
In diabetic subjects, there was a signiﬁcant correlation
between performance on the copying portion of the Rey-O
and fractional anisotropy in the posterior corona radiata,
with poorer scores associated with reduced fractional
anisotropy (Table 2). These subjects also demonstrated a
signiﬁcant association between longer time required to
complete the Grooved Pegboard Test, using both the
nondominant hand and dominant hand, and reduced frac-
tional anisotropy in the optic radiation, posterior corona
radiata, and splenium of the corpus callosum (Table 2).
Control subjects demonstrated a similar correlation be-
tween performance on the Grooved Pegboard Test and
fractional anisotropy in the optic radiation (dominant
hand only) and, unlike diabetic subjects, the fractional
anisotropy in the posterior body of the corpus callosum
(both hands) (Table 2). For all subjects, correlation be-
tween Rey-O and fractional anisotropy in the posterior
corona radiata is shown in Fig. 3. To assess the effects of
microvascular complications, the group with diabetes was
divided into those with (n 
 8) and without (n 
 17) such
complications; both subgroups had signiﬁcantly lower
fractional anisotropy in the posterior corona radiata than
controls, and those with microvascular complications also
had signiﬁcantly lower Rey-O scores (Table 3).
Correlation of DTI with characteristics of diabetic
subjects. Age, duration of diabetes, and A1C were nega-
tively correlated with reduced fractional anisotropy of the
optic radiation and posterior corona radiata, whereas
duration of diabetes was also negatively correlated with
reduced fractional anisotropy of the splenium of the
corpus callosum (Table 4). No signiﬁcant correlations
were identiﬁed between severe hypoglycemia or microvas-
cular complications and reduced fractional anisotropy in
any of the major white matter tracts.
FIG. 1. Fractional anisotropy in major brain regions. A: Superior
frontal region, inferior frontal region, occipital region, and region
superior to corpus callosum (going clockwise starting at top left).
There is 15% overlap between the frontal regions and the region
superior to the corpus callosum. B: Fractional anisotropy in major
brain regions; there was no signiﬁcant difference in any of the major
regions. , type 1 diabetic subjects; f, control subjects. Data are
means  SE.
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In this investigation, we found that white matter integrity,
as measured by fractional anisotropy using DTI, was lower
in several white matter tracts, including the posterior
corona radiata and optic radiation, in patients with long-
standing type 1 diabetes compared with age- and sex-
matched controls. We also observed there to be a
signiﬁcant correlation between reduced fractional anisot-
ropy in white matter tracts and reduced performance on
neurocognitive tests thought to assess white matter func-
tion, including the Rey-O copy and the Grooved Pegboard
Test. Together, these results demonstrate for the ﬁrst time
that microstructural abnormalities can be identiﬁed in the
brains of subjects with long-standing type 1 diabetes that
may underlie the cognitive dysfunction identiﬁed in this
population. This work may open the door for the develop-
ment of a novel biomarker for cognitive dysfunction that
can be used to better understand the cerebral complica-
tions of diabetes. If such a biomarker can be developed,
future study could focus on identifying interventions that
can prevent the appearance or slow the progression of
white matter microstructural changes in patients with
diabetes.
Over the last 10 years, investigators have used a variety
of imaging techniques, including MRI, single photon emis-
sion computed tomography (30,31), and positron emission
tomography (32), to determine whether structural abnor-
malities could be identiﬁed in the brains of patients with
FIG. 2. Fractional anisotropy of speciﬁc white matter tracts. A: Left-coronal view: corona radiata* (red), superior longitudinal fasciculus
(yellow), corpus callosum isthmus (blue), and cingulum (green). Middle-saggital view: genu (green), rostral body (purple), anterior midbody
(yellow), posterior midbody (red), isthmus (blue), and splenium (teal) of corpus callosum. Right-axial view: optic radiation* (orange). *P < 0.002
between diabetic subjects and controls. B: Fractional anisotropy in posterior corona radiata and optic radiation. , type 1 diabetic subjects; f,
control subjects. *P < 0.002 between diabetic subjects and controls. Data are means  SE. (Please see http://dx.doi.org/10.2337/db08-0724 for a
high-quality digital representation of this image.)
TABLE 2
Spearman correlation coefﬁcients between fractional anisotropy and neurocognitive measurements (scores) in type 1 diabetic
subjects and control subjects
Optic radiation
Posterior corona
radiata
Splenium corpus
callosum
Posterior body of
corpus callosum
Type 1
diabetes Control
Type 1
diabetes Control
Type 1
diabetes Control
Type 1
diabetes Control
Rey-O copy 0.10 0.10 0.46* 0.16 0.06 0.06 0.07 0.02
Grooved Peg Board, nondominant 0.66* 0.42* 0.72* 0.04 0.56* 0.20 0.32 0.60*
Grooved Peg Board, dominant 0.40* 0.39 0.70* 0.09 0.48* 0.05 0.24 0.53*
*Signiﬁcantly different from zero (P  0.05).
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signal lesions in cerebral white matter (or leukoaraiosis)
in these patients, most studies have not conﬁrmed this
ﬁnding (1,33,34). Others have found increased cerebral
spinal ﬂuid and cerebral global atrophy (35,36), stable
hippocampal and amygdala volumes (36), and decreased
cerebral gray matter density (37,38) in type 1 diabetic
subjects. Some of these structural abnormalities have
corresponded to age of diabetes onset (35), A1C levels,
hypoglycemia (37), and the presence of retinopathy (38).
Recently, Wessels et al. (4) applied MRI voxel-based
morphometry to measure white matter volumes in patients
with type 1 diabetes and found subjects with proliferative
retinopathy to have signiﬁcantly smaller white matter
volumes than diabetic subjects who were free of prolifer-
ative retinopathy and control subjects without diabetes. In
the Wessels et al. study, reduced white matter volume
correlated with worse performances on tests for attention,
speed of information processing, and executive function.
Whether reduced white matter volumes correlates with a
reduction in fractional anisotropy is uncertain, but in our
study, we did not ﬁnd a relationship between the presence
of retinopathy and either reduced fractional anisotropy or
mild cognitive impairment. Future investigation should
focus on this point because an association with retinopa-
thy suggests that a common mechanism may be responsi-
ble for the development of both retinopathy and changes
in white matter structure.
Previous studies that were designed to assess neurocog-
nitive dysfunction in patients with type 1 diabetes identi-
ﬁed abnormalities with information processing (1–4),
psychomotor efﬁciency (1,2), motor speed (3,5–7), visuo-
construction (4,8), attention (4), somatosensory examina-
tion, motor strength (7), and executive function (9).
Generally, these cognitive domains, which require the
integration of several different tasks, are thought to be
associated with the integrity of the white matter tracts that
connect gray matter regions. In selecting our neurocogni-
tive battery, we focused on measures like the PASAT, the
DVT, the Grooved Pegboard Test, and the Trails A and B,
which have previously identiﬁed differences in “psy-
chomotor efﬁciency” between subjects with and without
diabetes (2). We also selected measures that assessed
other white matter function domains (e.g., processing
speed, attention, and visual-spatial processing), such as
the JLO, the Trails A and B, the PASAT, the Rey-O, the
Grooved Pegboard Test, the CPT-II, and the DVT. Impor-
tantly, our battery also included the WASI, a test that
screens for intellectual ability, as a control because most
studies in type 1 diabetic subjects show no deﬁcits in
general intelligence (1–3). Our results demonstrated that
no differences could be identiﬁed between type 1 diabetic
FIG. 3. Rey-O copy score versus fractional anisotropy in the posterior corona radiata. Overall Spearman correlation  0.43 (P  0.0018). E,
Control subjects; U, diabetic subjects without microvascular complications; Œ, diabetic subjects with microvascular complications.
TABLE 3
Comparison of fractional anisotropy in diabetic subjects with microvascular complications, diabetic subjects without microvascular
complications, and control subjects
Diabetic subjects with
microvascular
complications
Diabetic subjects with
no microvascular
complications Control subjects
F test
P value
Posterior corona radiata 0.4350  0.0097
a 0.4470  0.0059
a 0.4710  0.0042
b 0.0003
Rey-O 30  1.3
a 32  0.8
ab 33  0.6
b 0.0696
Data are means  SE. Comparisons are within rows: means that do not share letters are signiﬁcantly different (P  0.05).
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of the other tests performed. Most likely, this is secondary
to our relatively small sample size, and with a larger
number, perhaps we would have found signiﬁcance in
such tests as the Rey-O Copy and the Grooved Peg Board
Test. Nevertheless, there were signiﬁcant associations
between these neurocognitive tests and reduced fractional
anisotropy in patients with type 1 diabetes.
In this investigation, we used DTI to evaluate white
matter microstructure. Although this form of imaging is
known to measure the magnitude and directionality of
water diffusion in tissues, what speciﬁc biochemical or
morphological abnormality underlies the change in diffu-
sion remains unknown. Like diabetes (39), many of the
diseases that have similar changes in fractional anisotropy
are associated with increases in oxidative stress, including
chronic alcoholism (40), depression (41), Alzheimer’s dis-
ease (42), chronic cocaine use (43), schizophrenia (44),
and HIV infection (45). Based on this, it is tempting to
think that oxidative stress could affect the integrity of
myelinated ﬁbers in vivo.
There were several limitations to this study. Historical
information about the diabetic subjects was limited to
self-report and a single A1C value. We did not conﬁrm the
presence or absence of retinopathy in our subjects, and if
we had, we may have found an association between white
matter structure/function and retinopathy as did Wessels
et al. (4,38). We did identify a signiﬁcant relationship
between A1C and fractional anisotropy, but an examina-
tion of the relationship between a measure of long-term
glycemia and changes in white matter microstructure
would provide greater understanding of the role of chronic
hyperglycemia in the development of reduced fractional
anisotropy. Similarly, if a detailed history of hypoglycemia
events and an assessment of hypoglycemia unawareness
had been obtained, we may have been able to identify a
link between hypoglycemia and structural changes as
Musen et al. (37) did using MRI. Reduced fractional
anisotropy was correlated with duration of diabetes; how-
ever, it was also correlated with increasing age. Future
studies hopefully will be needed to conﬁrm whether the
duration of diabetes correlates with fractional anisotropy
independent of age.
In summary, we found that DTI reveals white matter
microstructure deﬁcits (reduced fractional anisotropy) in
patients with longstanding type 1 diabetes compared with
controls. In addition, white matter microstructure deﬁcits
seen in type 1 diabetic subjects correlate with impaired
performance on neurocognitive tests that are thought to
be associated with white matter function. Based on these
ﬁndings, prospective, longitudinal studies are needed to
both better understand the natural evolution of cognitive
dysfunction in type 1 diabetes and to establish DTI as an
ideal methodology to follow cognitive dysfunction in dia-
betes. If further studies conﬁrm our ﬁndings correlating
diabetes, white matter microstructural changes, and neu-
rocognitive dysfunction, future work will determine what
factors will modify the progression of this diabetic com-
plication (i.e., reducing A1C levels, novel pharmacological
interventions, etc.).
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